Scientists unveil benefits and risks of blockbuster weight-loss drugs EuronewsMapping the effectiveness and risks of GLP-1 receptor agonists Nature.comSweeping review suggests weight-loss drugs’ effect on 175 conditions The Washington PostWeight-loss jabs linked to reduced risk of 42 conditions including dementia The GuardianOzempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind Livescience.com